Share on LinkedInShare on LinkedIn

ARTICLE · 21 JUNE 2013

Attorneys React To High Court's Gene Patent Ruling

Gerard Norton was quoted in the Law360 article "Attorneys React to High Court's Gene Patent Ruling." While the full text can be found in the June 13, 2013, issue of Law360, a synopsis is noted below.

United StatesIntellectual Property

Law360

Gerard Norton was quoted in the Law360 article "Attorneys React to High Court's Gene Patent Ruling." While the full text can be found in the June 13, 2013, issue of Law360, a synopsis is noted below. 

The U.S. Supreme Court struck down Myriad Genetics Inc.'s patents on isolated DNA associated with breast cancer risk on Thursday, unanimously ruling that human genes cannot be patented.

Gerard Norton was one of the attorneys who weighed in on the ruling, saying, "While this has been referred to as a gene patent case, the question involved isn't about genes inside any particular human being, but rather about synthetic molecules made in the laboratory for diagnostic purposes. The implications span the fields of pharmaceuticals, biotechnology, agriculture and others, and could have a wide-reaching impact on innovation. Also, concerns surround the impact on further development of diagnostics in the area of personalized medicine. These tests can help determine

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from